News Coverage 03.10.20 Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited immune cells can survive and thrive after infusion into cancer patients Related Announcement PICI Network Presenters at #KScelltherapy23 Our Impact 2022 Year in Review Announcement PICI Network Researchers to Present at #ASH22